Patients deserve affordable access to the best healthcare possible. That’s why Pfizer invests in research and development: to produce groundbreaking treatments that improve people’s lives. It’s this investment in innovation that enables our scientists to make dramatic strides in healthcare. Their work advances life-changing therapies for the patients we serve.
Pfizer provided treatments for 2.4 million cancer patients and 64 million patients with cardiovascular disease in the second quarter of 2020.
To help even more patients access the medications they depend on, we need smart public policies that support both access and innovation. Americans deserve healthcare solutions that:
- Increase affordable access to breakthrough treatments.
- Protect pharmaceutical innovation to discover life-saving cures — such as increasing access to biosimilars.
- Deliver meaningful healthcare savings directly to patients through rebate reform that cuts out the middlemen.
- Promote market competition and reject foreign price controls on prescription drugs.
As the election season ramps up, Americans need to hear solutions for protecting innovation while improving patient access to life-saving treatments!